Autoimmune Conditions in Dogs: Types, Symptoms, and Treatment

Autoimmune conditions occur when the immune system — the body’s defense against foreign threats — mistakenly identifies the body’s own cells or tissues as targets and attacks them. In dogs, autoimmune diseases can affect virtually any organ system, though certain conditions involving the blood, skin, and joints are diagnosed most frequently. Understanding the most common autoimmune conditions in dogs can help owners recognize warning signs and navigate diagnosis and treatment.

What Is an Autoimmune Condition?

In a healthy immune system, the body distinguishes between “self” (its own cells) and “non-self” (bacteria, viruses, and other foreign material). Autoimmune disease develops when this distinction breaks down, and the immune system launches an attack against the body’s own tissues.

In dogs, the trigger for most autoimmune conditions is not fully understood. Genetic predisposition plays a role in some breeds. Secondary causes — including certain medications, infections, and cancer — can also trigger autoimmune reactions, making a thorough workup important when a dog is first diagnosed.

Common Autoimmune Conditions in Dogs

Immune-Mediated Hemolytic Anemia (IMHA)

IMHA is among the most life-threatening autoimmune conditions in dogs. The immune system produces antibodies that coat and destroy red blood cells, causing a rapid drop in the red cell count. Dogs can deteriorate quickly and require emergency hospitalization.

According to VCA Animal Hospitals¹, clinical signs include pale or yellow (jaundiced) gums, extreme lethargy, rapid or labored breathing, weakness, and collapse. Because red blood cells carry oxygen, their rapid loss deprives tissues of oxygen, and can become life-threatening within days.

Treatment typically requires hospitalization, immunosuppressive medications (corticosteroids plus additional agents such as azathioprine or mycophenolate), and sometimes blood transfusions. Some cases are secondary to infections, drug reactions, or cancer — identifying and addressing an underlying trigger significantly improves outcomes.

Immune-Mediated Thrombocytopenia (IMT)

IMT involves immune-mediated destruction of platelets — the cells responsible for blood clotting. Affected dogs may show bruising, small pinpoint hemorrhages (petechiae) on the skin or gums, nosebleeds, blood in the urine or stool, or prolonged bleeding from minor wounds.

Like IMHA, IMT can develop rapidly and requires prompt veterinary evaluation. The primary treatment is corticosteroid immunosuppression, with additional agents added for severe or refractory cases. Many dogs respond well and achieve remission; others require ongoing low-dose maintenance therapy.

Pemphigus Foliaceus

Pemphigus foliaceus is the most commonly diagnosed cutaneous (skin) autoimmune disease in dogs. The immune system attacks proteins that hold the superficial skin layers together, causing fluid-filled blisters (pustules) that rupture and form thick crusts.

The condition typically affects the face, ears, and paw pads first and may spread over time. Affected skin can become severely crusted, painful, and prone to secondary bacterial infection. Dogs may also develop fever, lethargy, and lymph node enlargement when the condition is widespread.

Diagnosis is confirmed by skin biopsy. Treatment combines topical and systemic immunosuppression — often corticosteroids with tetracycline-niacinamide as a less aggressive option in mild cases. Pemphigus foliaceus rarely resolves fully, but most dogs achieve good disease control with appropriate management.

Lupus in Dogs

Two forms of lupus affect dogs:

Discoid lupus erythematosus (DLE) is the more common and benign form. It is primarily a skin disease affecting the nasal planum (the smooth, moist surface of the nose), causing loss of pigmentation, ulceration, and crusting confined to the face. DLE does not affect internal organs. Sun exposure worsens the condition, so affected dogs should minimize direct sunlight. Treatment includes topical therapy and, when needed, systemic immunomodulatory medications.

Systemic lupus erythematosus (SLE) is a more serious, multi-system disease in which autoantibodies attack multiple tissues — including the skin, joints, kidneys, and blood cells. Clinical signs vary widely and can include shifting lameness, skin lesions, anemia, proteinuria (protein in the urine indicating kidney involvement), and neurological signs. SLE requires more aggressive immunosuppression and careful long-term monitoring.

Immune-Mediated Polyarthritis

Immune-mediated polyarthritis (IMPA) involves inflammation of multiple joints driven by the immune system rather than infection or degenerative changes. Affected dogs often present with a characteristic shifting leg lameness — limping that moves from one leg to another on different days — along with joint swelling, stiffness, and fever.

A critical diagnostic step is ruling out infectious causes (such as tick-borne diseases like ehrlichiosis or Lyme disease) before committing to immunosuppressive treatment, as treating an infectious arthritis with steroids alone can worsen the underlying infection.

Diagnosing Autoimmune Conditions

Because autoimmune diseases mimic many other conditions, diagnosis typically requires several steps:

The foundation of treatment for most autoimmune conditions in dogs is immunosuppression — reducing the immune system’s activity to stop it from attacking the body’s own tissues.

According to the American Veterinary Medical Association (AVMA)², corticosteroids (prednisone or prednisolone) are the most commonly used first-line agents. For conditions that don’t respond adequately, or where the steroid dose needs to be reduced to manage side effects, additional immunosuppressants are added — most commonly azathioprine, mycophenolate, or cyclosporine.

Treatment is typically lifelong for most autoimmune conditions, though many dogs are eventually maintained on lower doses after achieving stable disease control. Regular monitoring of blood counts, organ function, and clinical signs guides dose adjustments.

Prognosis and Long-Term Management

Prognosis varies significantly by condition. IMHA carries the most serious short-term risk. Pemphigus foliaceus and DLE are generally manageable long-term. SLE and refractory IMPA require careful, ongoing management and can be complicated by drug side effects over time.

The cost of diagnostics, specialist care, hospitalization, and long-term medication makes autoimmune disease one of the categories of dog health conditions where knowing what pet insurance covers can make a meaningful financial difference. For dogs whose autoimmune conditions are suspected to be secondary to cancer, understanding whether pet insurance covers cancer-related workups is also relevant.

When signs of severe anemia, uncontrolled bleeding, or acute collapse occur, knowing when to seek emergency care is critical — several autoimmune conditions, including IMHA and Addison’s disease, can escalate to life-threatening crises rapidly.

The right pet insurance plan should help support your pet through both unexpected accidents and health needs. Understanding what’s included in your policy can help you choose coverage that fits your pet’s lifestyle.

Spot Pet Insurance offers accident and illness coverage to help reimburse eligible costs related to covered injuries, illnesses, diagnostics, and treatment. Pet parents can also add optional preventive care coverage for routine services like annual exams, dental cleanings, and certain vaccines. Learn more about what pet insurance covers.